✦ LIBER ✦

25 Randomized phase II study of cisplatine gemcitabine (PG) versus mitomycine ifosfamide cisplatine (MIP) in non-small cell lung cancer (NSCLC): an interim analysis

✍ Scribed by Morere, Jean-Francois; Spano, Jean-Philippe; Pailler, Marie-Christine; Bouillet, Thierry; Morin, Franck; Kohn, Maurice; Virally, Jerome; Oudard, Stephane; David, Philippe; Fares, F.; Valeyre, Dominique; Azorin, Jacques; Breau, Jean-Luc

Book ID: 122716645
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 197 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(03)92716-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PD-086 A phase II randomised study of ge

PD-086 A phase II randomised study of gemcitabine-cisplatin (GP) vs mitomycin-ifosfamide-cisplatin (MIP) as neoadjuvant chemotherapy in resectable stage IIIA non-small cell lung cancer (NSCLC)

✍ Brechot, J.; Saintigny, P.; Azorin, J.; Valeyre, D.; Breau, J.; Morere, J.; Gnom 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Cisplatin-gemcitabine-vinorelbine (PGV)

Cisplatin-gemcitabine-vinorelbine (PGV) vs cisplatin-vinorelbine (PV) vs cisplatin-gemcitabine (PG) in advanced non-small cell lung cancer (NSCLC). Interim analysis of a SICOG phase III trial

✍ P. Comella; N. Panza; G.P. Nicolella; L. Manzione; V. Lorusso; R. Cioffi; G. Dec 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Results of a phase II study using MIP re

Results of a phase II study using MIP regimen (Mitomycin+ifosfamide+Cisplatin) in unresectable Non Small Cell Lung Cancer

✍ Dutin, J.P.; Lacroix, H.; Donnadieu, N.; Cumin, I.; Dabouis, G. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Treatment of stage IIIB-IV non small cel

Treatment of stage IIIB-IV non small cell lung cancer (NSCLC) with Gemcitabine, Ifosfamide, Cisplatin (GIP). A phase II study

✍ Boni, C.; Bisagni, G.; Savoldi, L.; Moretti, G.; Vignoli, R.; Franciosi, V.; Pez 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 93 KB

159 Phase II trial of gemcitabine in com

159 Phase II trial of gemcitabine in combination with cisplatin and ifosfamide in advanced non-small cell lung cancer (NSCLC)

✍ Mohedano, N.; Sanchez-Rovira, P.; Medina, B.; Flores-Gonzalez, E.; Moreno, M.A.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

A phase II/III randomised comparison of

A phase II/III randomised comparison of gemcitabine/carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIC) in advanced non-small cell lung cancer (NSCLC)

✍ Rudd, R.M; Gower, N.H; James, L.E; Gregory, W; Eisen, T.Q; Lee, S.M; Harper, P.G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB